D-892-2013 Class III Terminated
FDA drug recall D-892-2013 was initiated by American Health Packaging on Feb 4, 2013 and is designated Class III. Reason for recall: Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds. The recall status is terminated (terminated Aug 28, 2013). Affected quantity: 389 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 21, 2013
- Initiation Date
- Feb 4, 2013
- Termination Date
- Aug 28, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 389 cartons
Product description
buPROPion Hydrochloride Extended Release Tablets, USP 100 mg, 100 count carton, 10 blister cards of 10 individually blistered and labeled tablets, Rx only, Actavis South Atlantic LLC, Packaged and Distributed by: American Health Packaging, Columbus, OH --- NDC 68084-470-01
Reason for recall
Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds.
Distribution pattern
Nationwide
Code information
The following codes are affects by the recall: Lot #114500, Exipration Date 08/2013, repackaging date 12/04/2011.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-892-2013
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026